On Thursday, Shares of Facebook, Inc. (NASDAQ:FB), gained 0.43% to $87.29.
Facebook, declared that the company’s second quarter 2015 financial results will be released after market close on Wednesday, July 29, 2015.
Facebook will host a conference call to talk about its results at 2 p.m. PT / 5 p.m. ET the same day. The live webcast of the call can be accessed at the Facebook Investor Relations website at investor.fb.com, together with the company’s earnings press release, financial tables and slide presentation.
Facebook, Inc. operates as a social networking company worldwide. It provides a set of development tools and application programming interfaces that enable developers to integrate with Facebook to create mobile and Web applications.
Shares of Alder Biopharmaceuticals Inc. (NASDAQ:ALDR), inclined 1.61% to $51.75, during its last trading session.
Alder BioPharmaceuticals, declared that the underwriters of its formerly declared public offering of common stock have exercised in full their option to purchase an additional 674,157 shares of common stock. The closing of the sale of all shares occurred recently. Gross proceeds from the offering of an aggregate of 5,168,539 shares at a public offering price of $44.50 per share, before underwriting discounts and commissions and offering expenses, were about $230 million.
Credit Suisse, Leerink Partners and Wells Fargo Securities acted as joint book-running managers for the offering. Bernstein acted as co-manager for the offering.
Alder BioPharmaceuticals, Inc., a clinical-stage biopharmaceutical company, discovers, develops, and commercializes various therapeutic antibodies in the United States and Australia. It is developing monoclonal antibodies comprising ALD403, which has accomplished Phase Ib proof-of-concept trials to target calcitonin gene-related peptide for the prevention of migraine; Clazakizumab that has accomplished Phase IIb clinical trials that inhibits the pro-inflammatory cytokine interleukin-6 in the treatment of rheumatoid arthritis and psoriatic arthritis; and ALD1613, which is in preclinical stage of development for the treatment of Cushings disease.
Finally, Oceaneering International, Inc. (NYSE:OII), ended its last trade with 0.61% gain, and closed at $46.29.
Oceaneering International, declared it will release its second quarter 2015 earnings Wednesday, July 22, 2015, after 5:00 p.m. Eastern.
A conference call to talk about these results and the company’s future business outlook is planned for Thursday, July 23, 2015, at 11:00 a.m. Eastern.
Oceaneering International, Inc. provides engineered services and products primarily to the offshore oil and gas industry worldwide. The company’s Remotely Operated Vehicles (ROVs) segment offers submersible vehicles for drilling support in the oil and gas industry; and subsea hardware installation, construction, pipeline inspection, survey and facilities inspection, maintenance, and repair services.
DISCLAIMER:
This article is published by www.wsnewspublishers.com. The Content included in this article is just for informational purposes only. All information used in this article is believed to be from reliable sources, but we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, or reliability with respect to this article.
All visitors are advised to conduct their own independent research into individual stocks before making a purchase decision.
Information contained in this article contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, counting statements regarding the predictable continual growth of the market for the corporation’s products, the corporation’s ability to fund its capital requirement in the near term and in the long term; pricing pressures; etc.
Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, aims, assumptions, or future events or performance may be forward looking statements. Forward-looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements may be identified through the use of such words as expects, will, anticipates, estimates, believes, or by statements indicating certain actions may, could, should/might occur.
